AngioDynamics Reports Positive DIRECT Study Results for NanoKnife IRE in Pancreatic Cancer and Announces New CPT Code for 2027 AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow through the vascular system, expanding cancer treatment…
Johnson & Johnson Launches Shockwave C2 Aero Fly Coronary IVL Catheter to Cut Treatment Time in Half Johnson & Johnson (NYSE: JNJ) has announced the U.S. launch of its Shockwave C2 Aero Fly Coronary Intravascular Lithotripsy (IVL) Catheter, a next-generation…
BeOne Medicines Advances Solid Tumor Oncology Pipeline With New Data Across Breast, Lung and Gastrointestinal Cancers at ESMO 2026 BeOne Medicines Ltd., a global oncology company, announced that it will present new clinical data from its rapidly advancing solid tumor…
MED Institute Joins Novelna’s PULSE Consortium to Advance Wearable Biosensing Technology for Post-Heart Attack Monitoring MED Institute has joined Novelna Inc. and its consortium partners in the development of the Proactive Unified Longitudinal Sensing Ecosystem (PULSE), a next-generation wearable biosensing…
Doctors and Public Health Experts Call for Oral Health to Be Integrated Into Everyday Healthcare Doctors, public health specialists and dental professionals are urging governments, healthcare systems and medical practitioners to recognize oral health as an essential component of overall…
Medicinal Genomics Launches Rapid Pathogen Testing Solution for Dietary Supplement Manufacturers Medicinal Genomics has launched a rapid microbial testing solution designed to help dietary supplement manufacturers identify key foodborne and opportunistic pathogens faster than conventional culture-based testing methods. The new…
Fortitude Biomedicines to Present FTB-918 Preclinical Data for Axial Spondyloarthritis at ACR Convergence 2026 Fortitude Biomedicines, Inc., a biopharmaceutical company focused on developing precision antibody-based therapies for autoimmune diseases and cancer, has announced that its investigational candidate FTB-918 has been…
VITALiS Expands Collaboration With Applied BioCode to Support In-House Gastrointestinal Pathogen Testing VITALiS and Applied BioCode have announced an expanded collaboration aimed at increasing the adoption of gastrointestinal (GI) pathogen testing in commercial laboratories and physician office laboratory settings. Under…
Catalent Partners with Mantra to Develop and Manufacture Single-Serve OTC Oral Gel Products Catalent, Inc., a leading global contract development and manufacturing organization (CDMO) dedicated to helping people live better and healthier lives, has announced a commercial supply agreement with…
Glaukos Reports Positive Phase 4 Results for iDose TR Combined With Cataract Surgery in Glaucoma Patients Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company developing innovative treatments for glaucoma, corneal disorders, and retinal diseases, has announced positive…
Ascensia Diabetes Care Partners with Sava Technologies to Advance Wearable Microsensor Technology for Glucose Monitoring Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (Tokyo Stock Exchange: 6523), has announced a strategic partnership with Sava…
Glaukos Reports Positive Three-Year Phase 3 Extension Results for Epioxa in Keratoconus Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company developing innovative therapies for glaucoma, corneal disorders and retinal diseases, has announced positive topline results from a…